Last reviewed · How we verify

NCT07437144

Exploring the Effects of Shangshou Daoyin Method on Improving Sleep Quality, Quality of Life, and TCM Constitution in Breast Cancer Patients With Insomnia

Not yet recruiting NA Last updated 27 February 2026
What this trial tests

NA trial testing Shangshou Daoyin Method in Breast Cancer Patients Diagnosed With Stage 0-III in 76 participants. Not yet recruiting.

Timeline
2 March 2026
Primary endpoint
31 October 2026
31 December 2026

Quick facts

Lead sponsorChina Medical University Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment76
Start date2 March 2026
Primary completion31 October 2026
Estimated completion31 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

China Medical University Hospital

Who can join

20 and older, female only, with Breast Cancer Patients Diagnosed With Stage 0-III. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Breast cancer patients often experience insomnia and physical imbalances during and after treatment, indirectly affecting their quality of life. Therefore, the sleep quality, quality of life, and TCM constitution of breast cancer patients need to be taken seriously. Oral sleep aids are prone to causing additional side effects; therefore, in addition to medication, non-pharmacological therapies can be used to alleviate the insomnia caused by breast cancer patients, thereby improving their quality of life. Because guided exercises are simple to learn, gentle, safe, and can be performed without time constraints, clinicians can apply them to the care of breast cancer patients. It is hoped that the results of this study can provide a reference for other related research.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other China Medical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07437144.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing